Lv1
38 积分 2025-10-21 加入
Long-term safety and efficacy of antibody ALXN2220 for depletion of cardiac amyloid transthyretin: results of treatment beyond 12 months in the open-label extension of study NI006-101
5天前
已关闭
Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis
5天前
已完结
Long-term effects of patisiran on survival and cardiac parameters in patients with transthyretin-mediated cardiac amyloidosis: Post hoc analysis of APOLLO-B and cardiac subpopulation of APOLLO OLE
5天前
已完结
Proteomics Profiling Reveals Circulating Biomarkers and Dysregulated Pathways in Transthyretin Amyloid Cardiomyopathy
1个月前
已完结
Sodium-glucose cotransporter 2 inhibitors in transthyretin amyloid cardiomyopathy: navigating potential benefits and uncertainties
3个月前
已完结
Transthyretin Tetramer Destabilization and Increased Mortality in the General Population
4个月前
已完结
Biomarkers in Subclinical Transthyretin Cardiac Amyloidosis
5个月前
已完结
Serum Transthyretin as a Biomarker of Treatment Response in ATTR Cardiomyopathy
5个月前
已关闭
Unknowing the Unknown
6个月前
已关闭
Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis
6个月前
已完结
皖公网安备34019202002308
